Correlation Between HUTCHMED DRC and Soleno Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HUTCHMED DRC and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HUTCHMED DRC and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HUTCHMED DRC and Soleno Therapeutics, you can compare the effects of market volatilities on HUTCHMED DRC and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HUTCHMED DRC with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HUTCHMED DRC and Soleno Therapeutics.

Diversification Opportunities for HUTCHMED DRC and Soleno Therapeutics

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between HUTCHMED and Soleno is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding HUTCHMED DRC and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and HUTCHMED DRC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HUTCHMED DRC are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of HUTCHMED DRC i.e., HUTCHMED DRC and Soleno Therapeutics go up and down completely randomly.

Pair Corralation between HUTCHMED DRC and Soleno Therapeutics

Considering the 90-day investment horizon HUTCHMED DRC is expected to under-perform the Soleno Therapeutics. In addition to that, HUTCHMED DRC is 1.08 times more volatile than Soleno Therapeutics. It trades about -0.27 of its total potential returns per unit of risk. Soleno Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest  5,531  in Soleno Therapeutics on August 27, 2024 and sell it today you would earn a total of  191.00  from holding Soleno Therapeutics or generate 3.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HUTCHMED DRC  vs.  Soleno Therapeutics

 Performance 
       Timeline  
HUTCHMED DRC 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in HUTCHMED DRC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental indicators, HUTCHMED DRC is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Soleno Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Soleno Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Soleno Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

HUTCHMED DRC and Soleno Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HUTCHMED DRC and Soleno Therapeutics

The main advantage of trading using opposite HUTCHMED DRC and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HUTCHMED DRC position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.
The idea behind HUTCHMED DRC and Soleno Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets